piracetam has been researched along with Embryopathies in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current evidence suggests that the overall risk of major malformation after first trimester exposure to Levetiracetam is within the population baseline risk of 1-3%, with no apparent adverse effects on long term child development." | 2.50 | The fetal safety of Levetiracetam: a systematic review. ( Chaudhry, SA; Jong, G; Koren, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhry, SA | 1 |
| Jong, G | 1 |
| Koren, G | 1 |
1 review available for piracetam and Embryopathies
| Article | Year |
|---|---|
The fetal safety of Levetiracetam: a systematic review.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Female; Fetal Diseases; Fetus; Humans; Leveti | 2014 |